Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

Peptides

Volumn 22, Issue 12, 2001, Pages 2105-2112

  Nilsson, C L ^a   Brinkmalm, A ^a   Minthon, L ^b   Blennow, K ^a   Ekman, R ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer s disease; Cerebrospinal fluid; Frontotemporal dementia; Galanin; Mass spectrometry; Neuropeptide Y; Somatostatin

Indexed keywords

GALANIN; NEUROPEPTIDE Y; SOMATOSTATIN;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DEMENTIA; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MIDDLE AGED;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; GALANIN; HUMANS; MALE; MIDDLE AGED; NEUROPEPTIDE Y; SOMATOSTATIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0035747677     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00571-X     Document Type: Article

References (45)

1. H. Agren G. Lundqvist Low levels of somatostatin in human CSF mark depressive episodes Psychoneuroendocrinology 9 1984 233 248
2. C.M. Banki L. Karmacsi G. Bissette C.B. Nemeroff CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia Psychiatry Res 43 1992 13 21
3. J.A. Bard M.W. Walker T.A. Branchek R.L. Weinshank Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY J Biol Chem 45 1995 26762 26765
4. T. Bartfai T. Hökfelt U. Langel Galanin- a neuroendocrine peptide Crit Rev Neurobiol 7 1993 229 274
5. M. Bersani L. Thim T.N. Rasmussen J.J. Holst Galanin and galanin extended at the N-terminus with seven and nine amino acids are produced in and secreted from the porcine adrenal medulla in almost equal amounts Endocrinology 5 1991 2693 2698
6. 18–36 Int J Peptide Protein Res 33 1989 11 15
7. V. Chan-Palay Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer’s and Parkinson’s disease a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia J Comp Neurol 273 1988 543 557
8. K.L. Davis M. Davidson R.K. Yang B.M. Davis L.J. Siever R.C. Mohs T. Ryan E. Coccaro L. Bierer S.D. Targum CSF somatostatin in Alzheimer’s disease, depressed patients, and control subjects Biol Psychiatry 24 1988 710 712
9. L. Edvinsson L. Minthon R. Ekman L. Gustafson Neuropeptides in cerebrospinal fluid of patients with Alzheimer’s disease and dementia with frontotemporal lobe degeneration Dementia 4 1993 167 171
10. R. Ekman P. Juhasz M. Heilig H. Agren C.E. Costello Novel neuropeptide Y processing in human cerebrospinal fluid from depressed patients Peptides 17 1996 1107 1111
11. G. Fisone C.F. Wu S. Consolo Ö. Nordström N. Brynne T. Bartfai T. Melander T. Hökfelt Galanin inhibits acetylcholine release in the ventral hippocampus of the rat histochemical, autoradiographic, in vivo, and in vitro studies Proc Natl Acad Sci USA 84 1987 7339 7343
12. M. Folstein S. Folstein P. McHugh “Mini-mental State” a practical method for grading the cognitive state of patients for the clinician J Psychol Res 12 1975 189 198
13. S.M. Gentleman P. Falkai B. Bogerts M.T. Herrero J.M. Polak G.W. Roberts Distribution of galanin-like immunoreactivity in the human brain Brain Res 505 1989 311 315
14. C. Gerald M.W. Walker L. Criscione E.L. Gustafson C. Batzl-Hartmann K.E. Smith P. Vysse M.M. Durkin T.M. Laz D.L. Linemeyer A.O. Schaffhauser S. Whitebread K.G. Hofbauer R.I. Taber T.A. Branchek R.L. Weinshank A receptor subtype involved in neuropeptide-Y-induced food intake Nature 382 1996 168 171
15. L. Gustafson Frontal lobe degeneration of non-Alzheimer type. 2. Clinical and picture differential diagnosis Arch Gerontol Geriatr 6 1987 209 223
16. E. Habert-Ortoli B. Amiranoff I. Loquet M. Laburthe J.F. Mayaux Molecular cloning of a functional human galanin receptor Proc Natl Acad Sci USA 91 1994 9780 9783
17. S. Harajiri G. Wood D.M. Desiderio Analysis of proenkephalin A, proopiomelanocortin and protachykinin neuropeptides in human lumbar cerebrospinal fluid by reversed-phase high-performance liquid chromatography (HPLC), radioimmunoassay and enzymolysis J Chrom Biomed Appl 575 1992 213 222
18. M. Heilig M. Sjögren K. Blennow R. Ekman A. Wallin Cerebrospinal fluid neuropeptides in Alzheimer’s disease and vascular dementia Biol Psychiatry 38 1995 210 216
19. M.T. Hyyppä H. Alaranta K. Lahtela F. Nykvist M. Hurme F. Nyberg P. Le Grevés T. Sakurada L. Terenius Neuropeptide converting enzyme activities in CSF of low back pain patients Pain 43 1990 163 168
20. T. Kaneko G. Wood W.L. Crouch D.M. Desiderio Assay of preproenkephalin A processing enzymes in human lumbar cerebrospinal fluid Anal Biochem 215 1993 45 53
21. T. Land U. Langel T. Bartfai Hypothalamic degradation of galanin (1–29) and galanin (1–16) identification and characterization of the peptidolytic products Brain Res 558 1991 245 250
22. Y.M. Li P. Brostedt S. Hjertén F. Nyberg J. Silberring Capillary liquid chromatography-fast atom bombardment mass spectrometry using a high-resolving cation exchanger, based on a continuous chromatographic matrix application to studies on neuropeptide peptidases J Chromatogr B 664 1995 426 430
23. C. Lindh M. Thörnwall A.C. Hansen C. Post T. Gordh N. Ordeberg Nyberg Neuropeptide-converting enzymes in cerbrospinal fluid Acta Orthop Scand 67 1996 189 192
24. K. Maeda M. Yasuda H. Kaneda S. Maeda A. Yamadori Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man Neuropeptides 27 1994 323 332
25. R. Malessa M. Heimbach N.H. Brockmeyer U. Hengge W. Rascher M.C. Michel Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients relation to HIV encephalopathy J Neurol Sci 136 1996 154 158
26. E. Martignoni F. Blandini F. Petraglia C. Paccheti G. Bono G. Nappi Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson’s disease, multiple system atrophy and dementia of the Alzheimer type J Neural Transm (P-D Sect) 4 1992 191 205
27. G.D. McKhann D. Drachman S. Folstein R. Katzman D. Price E.M. Stadlan Clinical diagnosis of Alzheimer’s disease report on the NINCDS-ADRDA Work group under the auspices of department of health and human services task force on Alzheimer’s disease Neurology 34 1984 939 944
28. L. Minthon L. Edvinsson R. Ekman L. Gustafson Cerebrospinal fluid NPY-like immunoreactive levels in dementia with frontotemporal degeneration of non-Alzheimer type Dementia 1 1990 262 266
29. L. Minthon L. Edvinsson R. Ekman L. Gustafson Reduced lumbar cerebrospinal fluid somatostatin levels in Alzheimer’s disease and dementia with frontotemporal degeneration Dementia 2 1991 273 277
30. S.E. Molchan J.L. Hill R.A. Martinez B.A. Lawlor A.M. Mellow D.R. Rubinow G. Bissette C.B. Nemeroff T. Sunderland CSF somatostatin in Alzheimer’s disease, and major depression relationship to hypothalamic-pituitary-adrenal axis, and clinical measures Psychoneuroendocrinol 18 1993 509 519
31. C.L. Nilsson G. Karlsson J. Bergquist A. Westman R. Ekman Mass spectrometry of peptides in neuroscience Peptides 19 1998 781 789
32. C. Nilsson G. Karlsson K. Blennow M. Heilig R. Ekman Differences in the Neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients Peptides 17 1996 359 362
33. C.L. Nilsson A. Westman K. Blennow R. Ekman Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as studied by MALDI-MS Peptides 19 1998 1137 1146
34. S. Persson C. Post L. Alari F. Nyberg L. Terenius Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats Neurosci Lett 107 1989 318 322
35. A.R. Pierotti A.J. Harmar Multiple forms of somatostatin-like immunoreactivity in the hypothalamus and amygdala of the rat selective localization of somatostatin-28 in the median eminence J Endocr 105 1985 383 389
36. M.A. Raskind E.R. Peskind T.H. Lampe S.C. Risse G.J. Taborsky D. Dorsa Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and β-endorphin in Alzheimer’s disease Arch Gen Psychiatry 43 1986 382 388
37. K. Rissler S. Jost M. Mohadjer F. Mundinger H. Cramer Molecular size distribution of somatostatin-like immunoreactivity in the cerebroventricular fluid of neurosurgical patients Neurosci Res 4 1987 343 356
38. J.C. Schwartz M.L. Bouthenet B. Giros C. Gros C. Llorens-Cortes H. Pollard Neuropeptidases and neuropeptide inactivation in the brain K. Fuxe F. Agnati Volume transmission in the brain Novel mechanisms for neural transmission 1991 Raven Press New York 381 394
39. B. Spengler Post-source decay analysis in matrix assisted laser desorption/ionization mass spectrometry of biomolecules J Mass Spectrom 32 1997 1019 1036
40. K. Tatemoto A. Rökaeus H. Jörnvall T.J. McDonald V. Mutt Galanin-a novel biologically active peptide from porcine intestine FEBS Lett 164 1983 124 128
41. L. Terenius F. Nyberg Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid Int Rev Neurobiol 30 1988 101 121
42. L. Terenius F. Nyberg Peptidases and proteases in cerebrospinal fluid, significance in volume transmission K. Fuxe F. Agnati Volume transmission in the brain Novel mechanisms for neural transmission 1991 Raven Press New York 415 424
43. L. Vécsei B. Csala E. Widerlöv R. Ekman J. Czopf G. Pálffy Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis Brain Res Bull 25 1990 411 413
44. C. Wahlestedt S. Regunathan D.J. Reis Identification of cultured cells selectively expressing Y1-, Y2- or Y3-type receptors for neuropeptide Y/peptide YY Life Sci 50 1991 7 12
45. P.L. Wood P. Etienne S. Lal S. Gauthier S. Cajal N.P.V. Nair Reduced lumbar CSF somatostatin levels in Alzheimer’s disease Life Sci 31 1982 2037 2079